Skip to main content

Marcel Lamana Vallverdu

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Marcel Lamana Vallverdu

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Malalties neurovasculars

IP: Anna Rosell Novel
Collaborators: Mercedes Arrue Gonzalo, Joan Montaner Villalonga, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Anna Bonaterra Pastra, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Antonio Palasi Franco, Jesús Pizarro Gonzálvez, Paula Garcia Rodriguez, Miguel García Gabilondo, Nicolas Garcia Rodriguez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00656
Duration: 01/01/2022 - 30/06/2025

RICORS-ICTUS

IP: Anna Rosell Novel
Collaborators: Marcel Lamana Vallverdu, Anna Penalba Morenilla, Anna Bonaterra Pastra, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Jesús Pizarro Gonzálvez
Funding agency: Instituto de Salud Carlos III
Funding: 250214.8
Reference: RD21/0006/0007
Duration: 01/01/2022 - 31/12/2024

Implicaction of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy

IP: Maria Mar Hernandez Guillamon
Collaborators: Marcel Lamana Vallverdu, Anna Bonaterra Pastra, Jessica Camacho Soriano, Olga Maisterra Santos, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 169400
Reference: PI20/00465
Duration: 01/01/2021 - 30/06/2025

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

IP: Joan Montaner Villalonga
Collaborators: Marcel Lamana Vallverdu
Funding agency: EUROPEAN COMMISSION
Funding: 91282.5
Reference: AFFECT-EU_H2020_SC1BHC2019
Duration: 01/01/2020 - 31/03/2024

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Maria Luisa Pancorbo Lerma

Maria Luisa Pancorbo Lerma

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Rut Mora Buch

Rut Mora Buch

Postdoctoral researcher
Transfusional Medicine
Read more
Juliana Silva Cardoso

Juliana Silva Cardoso

Research assistant
Pediatric Neurology
Read more
Clara Roig Rabada

Clara Roig Rabada

Research assistant
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.